Related Experiment Video

Updated: Aug 24, 2025

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
07:01

Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models

Published on: May 10, 2022

1.6K

Antioxidant nanozymes for prevention of diseased kidney from failure

Qiunong Guan1, Caigan Du1

  • 1Department of Urological Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

Kidney International
|October 22, 2022
PubMed

Insights

Novel gold-platinum nanoparticles offer a promising solution to combat oxidative stress in kidney disease. These advanced antioxidants overcome the low bioavailability of natural options, potentially preventing kidney failure in chronic kidney disease patients.

Area of Science:

  • Biomedical Science
  • Nanotechnology
  • Nephrology

Background:

  • Oxidative stress, characterized by excessive free radicals, is a significant factor in kidney disease progression.
  • Current antioxidant therapies for kidney disease are limited by the poor bioavailability of natural compounds.
  • Effective management of chronic kidney disease (CKD) requires novel therapeutic strategies to mitigate oxidative damage.

Purpose of the Study:

  • To discuss the potential of novel antioxidant gold-platinum nanoparticles for managing kidney disease.
  • To explore the application of these nanoparticles in preventing kidney failure.
  • To address the limitations of traditional antioxidants in treating oxidative stress associated with CKD.

Main Methods:

  • Review and discussion of existing literature on oxidative stress in kidney disease.
  • Exploration of the properties and potential of gold-platinum nanoparticles as antioxidants.
  • Analysis of nanoparticle bioavailability and efficacy compared to natural antioxidants.

Main Results:

  • Gold-platinum nanoparticles exhibit potent antioxidant capabilities.
  • These nanoparticles demonstrate improved bioavailability, enhancing their efficacy against free radicals.
  • The unique properties of these nanoparticles suggest a promising therapeutic avenue for CKD.

Conclusions:

  • Antioxidant gold-platinum nanoparticles represent a significant advancement in the potential treatment of kidney disease.
  • Their enhanced bioavailability and efficacy could lead to improved prevention of kidney failure in CKD patients.
  • Further research into gold-platinum nanoparticles is warranted for clinical application in nephrology.

More Related Videos

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

8.9K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

778

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
53
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
40
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
70
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
56
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.3K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
64